Effect of the first year of COVID-19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system

María Isabel Bermúdez-Forero; Jonathan Andrés Soto-Viáfara; Paula Andrea Gardeazábal-Acuña; Diego Alexander Anzola-Samudio; Michel Andrés García-Otálora

doi:10.1111/tme.12828

Effect of the first year of COVID-19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system

Título traducido de la contribución: Efecto del primer año de pandemia por COVID-19 en la recolección y uso de componentes sanguíneos en Colombia monitoreados a través del sistema nacional de hemovigilancia

María Isabel Bermúdez-Forero, Jonathan Andrés Soto-Viáfara, Paula Andrea Gardeazábal-Acuña, Diego Alexander Anzola-Samudio, Michel Andrés García-Otálora

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

8 Citas (Scopus)

Resumen

Objetivo: Este trabajo pretendía establecer los efectos de la pandemia de COVID-19 en la extracción de sangre y el uso de hemoderivados al final del primer año. Antecedentes: La llegada del SARS-CoV-2 a Colombia el 6 de marzo de 2020, desencadenó el cierre de fronteras y el bloqueo obligatorio a partir del 23 de marzo de 2020. Métodos/Materiales: El Instituto Nacional de Salud de Colombia administra la base de datos Nacional de casos confirmados de SARS-CoV-2 y el Sistema Nacional de Hemovigilancia. Se examinaron los casos positivos de SARS-CoV-2 identificados entre el 6 de marzo de 2020 y el 6 de marzo de 2021, mediante pruebas RT-PCR positivas (72,8%) o antígeno reactivo (27,2%). También analizamos la información de donantes aceptados y diferidos proporcionada por el 100% de los bancos de sangre y los pacientes transfundidos notificados por el 83% de los centros de salud de todo el país, entre el 1 de marzo de 2019 y el 28 de febrero de 2021. Resultados: Colombia registró 2 273 245 casos de SRAS-CoV-2. De estos, 60 412 personas fallecieron por COVID-19 (2,7%) y 2 172 418 individuos se recuperaron (95,6%). Se procesaron 11 659 216 muestras de SARS-CoV-2 en todo el país. Las personas de entre 20 y 39 años concentraron el 44,4% de los casos de SRAS-CoV-2. Hubo 773 569 donaciones de sangre, principalmente de población de 20 a 39 años (60,5%). La pandemia provocó una reducción de 155 393 donaciones de sangre (16,7%) y 51 823 aplazamientos totales (33,7%). Se observó un descenso del 18,4% de los donantes voluntarios y un aumento del 37,3% de las donaciones de familiares/reemplazos. Se transfundieron 399.453 pacientes y se administraron 1.179.895 componentes sanguíneos (-8,7% y -13,9% respecto a marzo 2019-febrero 2020). Conclusiones: Los bloqueos obligatorios en Colombia disminuyeron la recolección y el uso de sangre, lo que resultó en una reducción de los componentes sanguíneos transfundidos a pacientes individuales.

Título traducido de la contribución	Efecto del primer año de pandemia por COVID-19 en la recolección y uso de componentes sanguíneos en Colombia monitoreados a través del sistema nacional de hemovigilancia
Idioma original	Inglés estadounidense
Páginas (desde-hasta)	421-430
Número de páginas	10
Publicación	Transfusion Medicine
Volumen	31
N.º	6
DOI	https://doi.org/10.1111/tme.12828
Estado	Publicada - oct. 24 2021

Áreas temáticas de ASJC Scopus

Hematología

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1111/tme.12828

Otros archivos y enlaces

Citar esto

@article{d0ff1e3c380443d88bc022ff6c2b929b,

title = "Effect of the first year of COVID-19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system",

abstract = "Objective: This work aimed to establish the effects of the COVID-19 pandemic on blood collection and blood product usage at the end of the first year. Background: The arrival of SARS-CoV-2 to Colombia on March 6, 2020, triggered closure of borders and mandatory lockdown from March 23, 2020. Methods/Materials: The Colombian National Institute of Health administers the National database of confirmed cases of SARS-CoV-2 and the National Haemovigilance System. We examined positive SARS-CoV-2 cases identified between March 6, 2020, and March 6, 2021, using positive RT-PCR testing (72.8%) or reactive antigen (27.2%). We also analysed accepted and deferred donors' information provided by 100% of blood banks and transfused patients notified by 83% of health care facilities nationwide, between March 1, 2019, to February 28, 2021. Results: Colombia registered 2 273 245 SARS-CoV-2 cases. From these, 60 412 people died from COVID-19 (2.7%) and 2 172 418 individuals recovered (95.6%). There were 11 659 216 SARS-CoV-2 processed samples nationwide. People between the ages of 20 and 39 years concentrated 44.4% of the SARS-CoV-2 cases. There were 773 569 blood donations, mainly from a 20-39-year-old population (60.5%). The pandemic caused a reduction of 155 393 blood donations (16.7%) and 51 823 total deferrals (33.7%). An 18.4% drop in volunteer donors and a 37.3% increase in donations from family/replacements members were observed. There were 399 453 transfused patients and 1 179 895 blood components administered (−8.7% and − 13.9% compared to March 2019–February 2020). Conclusion: Mandatory lockdowns in Colombia decreased blood collection and usage, resulting in a reduction of blood components transfused to individual patients.",

author = "Berm{\'u}dez-Forero, {Mar{\'i}a Isabel} and Soto-Vi{\'a}fara, {Jonathan Andr{\'e}s} and Gardeaz{\'a}bal-Acu{\~n}a, {Paula Andrea} and Anzola-Samudio, {Diego Alexander} and Garc{\'i}a-Ot{\'a}lora, {Michel Andr{\'e}s}",

note = "Publisher Copyright: {\textcopyright} 2021 British Blood Transfusion Society.",

year = "2021",

month = oct,

day = "24",

doi = "10.1111/tme.12828",

language = "English (US)",

volume = "31",

pages = "421--430",

journal = "Transfusion Medicine",

issn = "0958-7578",

publisher = "Wiley-Blackwell",

number = "6",

}

Effect of the first year of COVID-19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system. / Bermúdez-Forero, María Isabel; Soto-Viáfara, Jonathan Andrés; Gardeazábal-Acuña, Paula Andrea et al.
En: Transfusion Medicine, Vol. 31, N.º 6, 24.10.2021, p. 421-430.

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

TY - JOUR

T1 - Effect of the first year of COVID-19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system

AU - Bermúdez-Forero, María Isabel

AU - Soto-Viáfara, Jonathan Andrés

AU - Gardeazábal-Acuña, Paula Andrea

AU - Anzola-Samudio, Diego Alexander

AU - García-Otálora, Michel Andrés

PY - 2021/10/24

Y1 - 2021/10/24

N2 - Objective: This work aimed to establish the effects of the COVID-19 pandemic on blood collection and blood product usage at the end of the first year. Background: The arrival of SARS-CoV-2 to Colombia on March 6, 2020, triggered closure of borders and mandatory lockdown from March 23, 2020. Methods/Materials: The Colombian National Institute of Health administers the National database of confirmed cases of SARS-CoV-2 and the National Haemovigilance System. We examined positive SARS-CoV-2 cases identified between March 6, 2020, and March 6, 2021, using positive RT-PCR testing (72.8%) or reactive antigen (27.2%). We also analysed accepted and deferred donors' information provided by 100% of blood banks and transfused patients notified by 83% of health care facilities nationwide, between March 1, 2019, to February 28, 2021. Results: Colombia registered 2 273 245 SARS-CoV-2 cases. From these, 60 412 people died from COVID-19 (2.7%) and 2 172 418 individuals recovered (95.6%). There were 11 659 216 SARS-CoV-2 processed samples nationwide. People between the ages of 20 and 39 years concentrated 44.4% of the SARS-CoV-2 cases. There were 773 569 blood donations, mainly from a 20-39-year-old population (60.5%). The pandemic caused a reduction of 155 393 blood donations (16.7%) and 51 823 total deferrals (33.7%). An 18.4% drop in volunteer donors and a 37.3% increase in donations from family/replacements members were observed. There were 399 453 transfused patients and 1 179 895 blood components administered (−8.7% and − 13.9% compared to March 2019–February 2020). Conclusion: Mandatory lockdowns in Colombia decreased blood collection and usage, resulting in a reduction of blood components transfused to individual patients.

AB - Objective: This work aimed to establish the effects of the COVID-19 pandemic on blood collection and blood product usage at the end of the first year. Background: The arrival of SARS-CoV-2 to Colombia on March 6, 2020, triggered closure of borders and mandatory lockdown from March 23, 2020. Methods/Materials: The Colombian National Institute of Health administers the National database of confirmed cases of SARS-CoV-2 and the National Haemovigilance System. We examined positive SARS-CoV-2 cases identified between March 6, 2020, and March 6, 2021, using positive RT-PCR testing (72.8%) or reactive antigen (27.2%). We also analysed accepted and deferred donors' information provided by 100% of blood banks and transfused patients notified by 83% of health care facilities nationwide, between March 1, 2019, to February 28, 2021. Results: Colombia registered 2 273 245 SARS-CoV-2 cases. From these, 60 412 people died from COVID-19 (2.7%) and 2 172 418 individuals recovered (95.6%). There were 11 659 216 SARS-CoV-2 processed samples nationwide. People between the ages of 20 and 39 years concentrated 44.4% of the SARS-CoV-2 cases. There were 773 569 blood donations, mainly from a 20-39-year-old population (60.5%). The pandemic caused a reduction of 155 393 blood donations (16.7%) and 51 823 total deferrals (33.7%). An 18.4% drop in volunteer donors and a 37.3% increase in donations from family/replacements members were observed. There were 399 453 transfused patients and 1 179 895 blood components administered (−8.7% and − 13.9% compared to March 2019–February 2020). Conclusion: Mandatory lockdowns in Colombia decreased blood collection and usage, resulting in a reduction of blood components transfused to individual patients.

UR - http://www.scopus.com/inward/record.url?scp=85117754413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85117754413&partnerID=8YFLogxK

U2 - 10.1111/tme.12828

DO - 10.1111/tme.12828

M3 - Article

C2 - 34693573

AN - SCOPUS:85117754413

SN - 0958-7578

VL - 31

SP - 421

EP - 430

JO - Transfusion Medicine

JF - Transfusion Medicine

IS - 6

ER -

Effect of the first year of COVID-19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system

Resumen

Áreas temáticas de ASJC Scopus

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto